Pure Bioscience Inc - Company Profile
Powered by 
All the sales intelligence you need on Pure Bioscience Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pure Bioscience Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pure Bioscience Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Pure Bioscience Inc (Pure Bioscience) develops and commercializes proprietary antimicrobial products that address health and environmental challenges related to pathogens and hygiene control. The company's technology platform, based on patented stabilized ionic silver, powers a range of solutions, with silver dihydrogen citrate (SDC) as its lead product. SDC is a broad-spectrum, non-toxic antimicrobial agent effective against resistant pathogens and viruses. The company’s product portfolio includes Pure Hard Surface, an EPA-registered disinfectant, and Pure Control, FDA-approved for poultry and produce processing. Pure Bioscience also offers multi-purpose cleaners, floor cleaners, and SDC as a raw material for personal care products. The company serves industries such as food processing, healthcare, hospitality, transportation, and personal care. Pure Bioscience is headquartered in El Cajon, California, the US.
Headquarters
United States of America
Address
771 Jamacha Road #512, El Cajon, California, 92019
Website
www.purebio.com
Telephone
1 619 5968600
No of Employees
11
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PURE (OTC)
Revenue (2024)
$2.2M
12.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
28.4%
(2024 vs 2023)
Market Cap*
$8.2M
Net Profit Margin (2024)
XYZ
36.2%
(2024 vs 2023)
* As of and is in US$
Pure Bioscience Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| PURE Hard Surface Disinfectant | PURE Bioscience |
| PURE Control | PURE |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In June, the company entered into a distribution agreement with Bonsai for the purchase and sale of SDC products. |
| 2025 | New Products/Services | In June, the company announced an application method for membrane treatment in the dairy and beverage industry using its flagship product, PURE Hard Surface. |
| 2025 | Contracts/Agreements | In January, the company entered into a distribution agreement with Hydrite Chemical Company, for the purchase and selling of non-toxic silver dihydrogen citrate (SDC) products. |
Competitor Comparison
| Key Parameters | Pure Bioscience Inc | The Clorox Co | Advantec MFS Inc | NovaSterilis Inc | PRIMUS Sterilizer Company LLC |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | El Cajon | Oakland | Dublin | Lansing | Omaha |
| State/Province | California | California | California | New York | Nebraska |
| No. of Employees | 11 | 7,600 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ivan Chen | Chairman | Executive Board | 2021 | 43 |
| Robert Bartlett | Chief Executive Officer; Director | Executive Board | 2023 | 80 |
| Tom Myers | Executive Vice President - Technology and Development; Director | Executive Board | 2021 | 73 |
| Jeff Kitchell | President; Secretary | Senior Management | 2025 | - |
| Mark Elliott | Vice President - Finance | Senior Management | 2015 | 50 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer